| BIOCON  Back to Income Statement | 
BIOCON Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,013 Cr | ₹1,023 Cr | ₹463 Cr | ₹648 Cr | ₹741 Cr | 
What is the latest Consolidated Net Profit of BIOCON ?
| Year | Consolidated Net Profit | 
|---|---|
| Mar2025 | ₹1,013 Cr | 
| Mar2024 | ₹1,023 Cr | 
| Mar2023 | ₹463 Cr | 
| Mar2022 | ₹648 Cr | 
| Mar2021 | ₹741 Cr | 
How is Consolidated Net Profit of BIOCON Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,013 Cr | -0.90 | |
| Mar2024 | ₹1,023 Cr | 120.99 | |
| Mar2023 | ₹463 Cr | -28.64 | |
| Mar2022 | ₹648 Cr | -12.44 | |
| Mar2021 | ₹741 Cr | - | |
Compare Consolidated Net Profit of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹50,404.9 Cr | 5% | 10.8% | 19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,751.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,634.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹124,437.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,871.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,333.0 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| BIOCON | 5% | 10.8% | 19.5% | 
| SENSEX | -0.2% | 5% | 5.4% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    